胆汁酸肠肝循环转运蛋白及FXR对其的调控机制

doi:10.11843/j.issn.0366-6964.2021.010.004

摘要/Abstract

摘要： 胆汁酸作为胆汁的重要成分，由肝以胆固醇为原料进行合成，能在外源食物及相关激素的刺激下与胆汁一同被排入消化道内，具有脂肪乳化、促进肠道吸收脂质、调节肝肠功能、增加能量消耗、改善胰岛素敏感性等作用，一般可通过经典途径和替代途径两种方式进行合成。肠肝循环能将从头合成的胆汁酸重新回收约95%，仅剩余5%会流失，经替代途径进行再补充，从而保障了胆汁酸池的动态平衡，因此，肠肝循环在调节胆汁酸稳态等方面具有重要作用。近年来，随着研究的深入，胆汁酸的代谢与运输机制逐渐明确，参与肠肝循环的转运蛋白功能也更加清晰，其中，法尼酯X受体（FXR）作为重要的核因子能通过与小异二聚体受体（SHP）、视黄酸受体α（RARα）等，联合成纤维细胞生长因子15/19（FGF15/19）对胆汁酸转运蛋白的表达量进行调控，进而影响胆汁酸稳态。本文将对胆汁酸肠肝循环过程中涉及到的重要转运蛋白及FXR对其的调节机制进行阐述，为今后进一步探究胆汁酸功能提供一定的理论基础。

关键词: 胆汁酸转运蛋白, 肠肝循环, FXR

Abstract: As an important component of bile, bile acid is synthesized by the liver using cholesterol as a raw material. It can be excreted into the digestive tract together with bile under the stimulation of exogenous food and related hormones. Bile acids can emulsify fat, promote intestinal absorption of lipids, and regulate liver and intestine functions, increasing energy consumption, improve insulin sensitivity. The bile acid, generally can be synthesized in two ways, the classical route and the alternative route. The enterohepatic circulation can recycle about 95% of the bile acids synthesized from the beginning, and only 5% which can be refilled through alternative ways to ensure the dynamic balance of the bile acid pool will be lost. Therefore, the enterohepatic circulation plays a vital role in regulating the homeostasis of bile acids. With the deepening of research, the metabolism and transport mechanisms of bile acids have been gradually clarified, and the functions of transporters involved in the enterohepatic circulation have become more clear in recent years. The farnesoid X receptor (FXR), as an important nuclear factor, can regulate the expression of bile acid transporter through small heterodimer receptor (SHP), retinoic acid receptor α (RARα), combined with fibroblast growth factor 15/19 (FGF15/19), and then affects bile acids homeostasis. This article describes the significant transporters involved in the enterohepatic circulation of bile acids and the regulatory mechanism of FXR, which will provide a theoretical basis for further exploration of bile acid functions in the future.

Key words: bile acids transporter, enterohepatic circulation, FXR

中图分类号:

Q548.5

杜雪儿, 王菁, 姚军虎, 曹阳春. 胆汁酸肠肝循环转运蛋白及FXR对其的调控机制[J]. 畜牧兽医学报, 2021, 52(10): 2721-2739.

DU Xue'er, WANG Jing, YAO Junhu, CAO Yangchun. Bile Acid Enterohepatic Circulation Transporter and Its Regulatory Mechanism by FXR[J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(10): 2721-2739.

参考文献 155

[1]	HOFMANN A F,HAGEY L R,KRASOWSKI M D.Bile salts of vertebrates:structural variation and possible evolutionary significance[J].J Lipid Res,2010,51:226-246.
[2]	MOLINARO A,WAHLSTRÖM A,MARSCHALL H U.Role of bile acids in metabolic control[J].Trends Endocrinol Metab,2018,29(1):31-41.
[3]	WINSTON J A,THERIOT C M.Diversification of host bile acids by members of the gut microbiota[J].Gut Microbes,2020,11(2):158-171.
[4]	LAMICHHANE S,SEN P,ALVES M A,et al.Linking gut microbiome and lipid metabolism:moving beyond associations[J].Metabolites,2021,11(1):55.
[5]	PERINO A,DEMAGNY H,VELAZQUEZ-VILLEGAS L,et al.Molecular physiology of bile acid signaling in health,disease,and aging[J].Physiol Rev,2021,101(2):683-731.
[6]	STEWART C J,AJAMI N J,O'BRIEN J L,et al.Temporal development of the gut microbiome in early childhood from the TEDDY study[J].Nature,2018,562(7728):583-588.
[7]	VAN BEST N,ROLLE-KAMPCZYK U,SCHAAP F G,et al.Bile acids drive the newborn's gut microbiota maturation[J].Nat Commun,2020,11(1):3692.
[8]	REUBEN A.The biliary cycle of Moritz Schiff[J].Hepatology,2005,42(2):500-505.
[9]	CHIANG J Y L,FERRELL J M.Bile acid metabolism in liver pathobiology[J].Gene Expr,2018,18(2):71-87.
[10]	BIDAULT-JOURDAINNE V,MERLEN G,GLÉNISSON M,et al.TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload[J].JHEP Rep,2021,3(2):100214.
[11]	DE HAAN L,VAN DER LELY S J,WARPS A L K,et al.Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis[J].J Clin Transl Res,2018,4(1):1-46.
[12]	PANDAK W M,REN S L,MARQUES D,et al.Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes[J].J Biol Chem,2002,277(50):48158-48164.
[13]	EGGINK H M,OOSTERMAN J E,DE GOEDE P,et al.Complex interaction between circadian rhythm and diet on bile acid homeostasis in male rats[J].Chronobiol Int,2017,34(10):1339-1353.
[14]	TIEMANN M,HAN Z H,SOCCIO R,et al.Cholesterol feeding of mice expressing cholesterol 7α-hydroxylase increases bile acid pool size despite decreased enzyme activity[J].Proc Natl Acad Sci U S A,2004,101(7):1846-1851.
[15]	TICHO A L,MALHOTRA P,DUDEJA P K,et al.Intestinal absorption of bile acids in health and disease[J].Compr Physiol,2019,10(1):21-56.
[16]	WANG D X,HARTMANN K,SEWERYN M,et al.Interactions between regulatory variants in CYP7A1(Cholesterol 7α-Hydroxylase) promoter and enhancer regions regulate CYP7A1 expression[J].Circ Genom Precis Med,2018,11(10):e002082.
[17]	ZINKHAN E K,YU B F,SCHLEGEL A.Prenatal exposure to a maternal high fat diet increases hepatic cholesterol accumulation in intrauterine growth restricted rats in part through microRNA-122 inhibition of Cyp7a1[J].Front Physiol,2018,9:645.
[18]	GRIFFITHS W J,CRICK P J,MELJON A,et al.Additional pathways of sterol metabolism:evidence from analysis of Cyp27a1-/-mouse brain and plasma[J].Biochim Biophys Acta Mol Cell Biol Lipids,2019,1864(2):191-211.
[19]	LI T G,APTE U.Bile acid metabolism and signaling in cholestasis,inflammation,and cancer[J].Adv Pharmacol,2015,74:263-302.
[20]	STYLES N A,FALANY J L,BARNES S,et al.Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver[J].J Lipid Res,2007,48(6):1305-1315.
[21]	CAMILLERI M.Bile acid diarrhea:prevalence,pathogenesis,and therapy[J].Gut Liver,2015,9(3):332-339.
[22]	BOYER J L.Bile formation and secretion[J].Compr Physiol,2013,3(3):1035-1078.
[23]	BANDO M K H,NELSON O L,KOGAN C,et al.Metabolic derangements and reduced survival of bile-extracted Asiatic black bears (Ursus thibetanus)[J].BMC Vet Res,2019,15(1):263.
[24]	LI T G,CHIANG J Y.Bile acid signaling in metabolic disease and drug therapy[J].Pharmacol Rev,2014,66(4):948-983.
[25]	THAKKAR N,SLIZGI J R,BROUWER K L R.Effect of liver disease on hepatic transporter expression and function[J].J Pharm Sci,2017,106(9):2282-2294.
[26]	HARDY D,BILL R M,JAWHARI A,et al.Functional expression of multidrug resistance protein 4 MRP4/ABCC4[J].SLAS Discov,2019,24(10):1000-1008.
[27]	CHAMBERS K F,DAY P E,ABOUFARRAG H T,et al.Polyphenol effects on cholesterol metabolism via bile acid biosynthesis,CYP7A1:a review[J].Nutrients,2019,11(11):2588.
[28]	NAUMANN S,SCHWEIGGERT-WEISZ U,EGLMEIER J,et al.In vitro interactions of dietary fibre enriched food ingredients with primary and secondary bile acids[J].Nutrients,2019,11(6):1424.
[29]	LECUREUR V,SUN D,HARGROVE P,et al.Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein[J].Mol Pharmacol,2000,57(1):24-35.
[30]	HAYASHI H,SUGIYAMA Y.Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11)[J].Mol Pharmacol,2009,75(1):143-150.
[31]	NICOLAOU M,ANDRESS E J,ZOLNERCIKS J K,et al.Canalicular ABC transporters and liver disease[J].J Pathol,2012,226(2):300-315.
[32]	NISHIDA T,GATMAITAN Z,CHE M X,et al.Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system[J].Proc Natl Acad Sci U S A,1991,88(15):6590-6594.
[33]	GERLOFF T,STIEGER B,HAGENBUCH B,et al.The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver[J].J Biol Chem,1998,273(16):10046-10050.
[34]	STRAUTNIEKS S S,BULL L N,KNISELY A S,et al.A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis[J].Nat Genet,1998,20(3):233-238.
[35]	DOMBROWSKI F,STIEGER B,BEUERS U.Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver[J].Lab Invest,2006,86(2):166-174.
[36]	HEEMSKERK S,VAN KOPPEN A,VAN DEN BROEK L,et al.Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia[J].Pflügers Arch,2007,454(2):321-334.
[37]	HILGENDORF C,AHLIN G,SEITHEL A,et al.Expression of thirty-six drug transporter genes in human intestine,liver,kidney,and organotypic cell lines[J].Drug Metab Dispos,2007,35(8):1333-1340.
[38]	GAO B,ST PIERRE M V,STIEGER B,et al.Differential expression of bile salt and organic anion transporters in developing rat liver[J].J Hepatol,2004,41(2):201-208.
[39]	CHEN H L,CHEN H L,LIU Y J,et al.Developmental expression of canalicular transporter genes in human liver[J].J Hepatol,2005,43(3):472-477.
[40]	MVLLER M,ISHIKAWA T,BERGER U,et al.ATP-dependent transport of taurocholate across the hepatocyte canalicular membrane mediated by a 110-kDa glycoprotein binding ATP and bile salt[J].J Biol Chem,1991,266(28):18920-18926.
[41]	STIEGER B,FATTINGER K,MADON J,et al.Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver[J].Gastroenterology,2000,118(2):422-430.
[42]	HAYASHI H,TAKADA T,SUZUKI H,et al.Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate:a comparison of human BSEP with rat Bsep[J].Biochim Biophys Acta Mol Cell Biol Lipids,2005,1738(1-3):54-62.
[43]	MITA S,SUZUKI H,AKITA H,et al.Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs[J].Drug Metab Dispos,2006,34(9):1575-1581.
[44]	SETCHELL K D R,HEUBI J E,SHAH S,et al.Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency[J].Gastroenterology,2013,144(5):945-955.e6.
[45]	HIRANO M,MAEDA K,HAYASHI H,et al.Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate,pravastatin[J].J Pharmacol Exp Ther,2005,314(2):876-882.
[46]	KIS E,IOJA E,NAGY T,et al.Effect of membrane cholesterol on BSEP/Bsep activity:species specificity studies for substrates and inhibitors[J].Drug Metab Dispos,2009,37(9):1878-1886.
[47]	STIEGER B.The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation[M]//FROMM M F,KIM R B.Drug Transporters.Berlin:Springer.2011:205-259.
[48]	LAM P,SOROKA C J,BOYER J L.The bile salt export pump:clinical and experimental aspects of genetic and acquired cholestatic liver disease[J].Semin Liver Dis,2010,30(2):125-133.
[49]	STRAUTNIEKS S S,BYRNE J A,PAWLIKOWSKA L,et al.Severe bile salt export pump deficiency:82 different ABCB11 mutations in 109 families[J].Gastroenterology,2008,134(4):1203-1214.e8.
[50]	HAYASHI H,SUGIYAMA Y.4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps[J].Hepatology,2007,45(6):1506-1516.
[51]	SOHAIL M I,DÖNMEZ-CAKIL Y,SZÖLLÖSI D,et al.The bile salt export pump:molecular structure,study models and small-molecule drugs for the treatment of inherited BSEP deficiencies[J].Int J Mol Sci,2021,22(2):784.
[52]	FUCHS C D,KRIVANEC S,STEINACHER D,et al.Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice[J].Liver Int,2020,40(6):1366-1377.
[53]	GARZEL B,ZHANG L,HUANG S M,et al.A Change in bile flow:looking beyond transporter inhibition in the development of drug-induced cholestasis[J].Curr Drug Metab,2019,20(8):621-632.
[54]	NOTENBOOM S,WEIGAND K M,PROOST J H,et al.Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs[J].Eur J Pharm Sci,2018,115:175-184.
[55]	KRAMER W,BURCKHARDT G,WILSON F A,et al.Bile salt-binding polypeptides in brush-border membrane vesicles from rat small intestine revealed by photoaffinity labeling[J].J Biol Chem,1983,258(6):3623-3627.
[56]	NIZAMUTDINOV D,DEMORROW S,MCMILLIN M,et al.Hepatic alterations are accompanied by changes to bile acid transporterexpressing neurons in the hypothalamus after traumatic brain injury[J].Sci Rep,2017,7(1):40112.
[57]	LIONARONS D A,BOYER J L,CAI S Y.Evolution of substrate specificity for the bile salt transporter ASBT (SLC10A2[J].J Lipid Res,2012,53(8):1535-1542.
[58]	AL-HILAL T A,CHUNG S W,ALAM F,et al.Functional transformations of bile acid transporters induced by high-affinity macromolecules[J].Sci Rep,2014,4(1):4163.
[59]	DAWSON P A.Role of the intestinal bile acid transporters in bile acid and drug disposition[M]//FROMM M F,KIM R B.Drug Transporters.Berlin:Springer.2011:169-203.
[60]	XIA X F,FRANCIS H,GLASER S,et al.Bile acid interactions with cholangiocytes[J].World J Gastroenterol,2006,12(22):3553-3563.
[61]	LUO Z L,CHENG L,WANG T,et al.Bile Acid transporters are expressed and heterogeneously distributed in rat bile ducts[J].Gut Liver,2019,13(5):569-575.
[62]	KUBITZ R,DRÖGE C,KLUGE S,et al.Genetic variations of bile salt transporters[J].Drug Discov Today Technol,2014,12:e55-e67.
[63]	RENNER O,HARSCH S,SCHAEFFELER E,et al.Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2):novel haplotype block including six newly identified variants linked to reduced expression[J].Hum Genet,2009,125(4):381-391.
[64]	RAUFMAN J P,SHANT J,GUO C Y,et al.Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling[J].J Cell Physiol,2008,215(2):538-549.
[65]	SALIC K,KLEEMANN R,WILKINS-PORT C,et al.Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-. Leiden mice[J].PLoS One,2019,14(6):e0218459.
[66]	MUSSO G,GAMBINO R,CASSADER M.Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis[J].Prog Lipid Res,2013,52(1):175-191.
[67]	TIESSEN R G,KENNEDY C A,KELLER B T,et al.Safety,tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus:a randomised placebo-controlled trial[J].BMC Gastroenterol,2018,18(1):3.
[68]	VAN DE PEPPEL I P,RAO A,DOMMERHOLT M B,et al.The beneficial effects of apical sodium-dependent bile acid transporter inactivation depend on dietary fat composition[J].Mol Nutr Food Res,2020,64(24):2000750.
[69]	DAWSON P A.Hepatic bile acid uptake in humans and mice:multiple pathways and expanding potential role for gut-liver signaling[J].Hepatology,2017,66(5):1384-1386.
[70]	KAIKAUS R M,BASS N M,OCKNER R K.Functions of fatty acid binding proteins[J].Experientia,1990,46(6):617-630.
[71]	LIN M C,KRAMER W,WILSON F A.Identification of cytosolic and microsomal bile acid-binding proteins in rat ileal enterocytes[J].J Biol Chem,1990,265(25):14986-14995.
[72]	GONG Y Z,EVERETT E T,SCHWARTZ D A,et al.Molecular cloning,tissue distribution,and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol[J].Proc Natl Acad Sci U S A,1994,91(11):4741-4745.
[73]	FAVRETTO F,CECCON A,ZANZONI S,et al.The unique ligand binding features of subfamily-II iLBPs with respect to bile salts and related drugs[J].Prostaglandins Leukot Essent Fatty Acids,2015,95:1-10.
[74]	ZIMMERMAN A W,VAN MOERKERK H T B,VEERKAMP J H.Ligand specificity and conformational stability of human fatty acid-binding proteins[J].Int J Biochem Cell Biol,2001,33(9):865-876.
[75]	HORVÁTH G,BENCSURA Á,SIMON Á,et al.Structural determinants of ligand binding in the ternary complex of human ileal bile acid binding protein with glycocholate and glycochenodeoxycholate obtained from solution NMR[J].FEBS J,2016,283(3):541-555.
[76]	BADIEE M,TOCHTROP G P.Bile acid recognition by mouse ileal bile acid binding protein[J].ACS Chem Biol,2017,12(12):3049-3056.
[77]	D'ONOFRIO M,ZANZONI S,MUNARI F,et al.The long variant of human ileal bile acid-binding protein associated with colorectal cancer exhibits sub-cellular localization and lipid binding behaviour distinct from those of the common isoform[J].Biochim Biophys Acta Gen Subj,2017,1861(9):2315-2324.
[78]	PRASLICKOVA D,TORCHIA E C,SUGIYAMA M G,et al.The ileal lipid binding protein is required for efficient absorption and transport of bile acids in the distal portion of the murine small intestine[J].PLoS One,2012,7(12):e50810.
[79]	HABIB S M,ZWICKER B L,WYKES L,et al.Sexually dimorphic response of mice to the Western-style diet caused by deficiency of fatty acid binding protein 6(Fabp6)[J].Physiol Rep,2021,9(3):e14733.
[80]	LI H Z,LIU Y H,ZHANG X S,et al.Medium-chain fatty acids decrease serum cholesterol via reduction of intestinal bile acid reabsorption in C57BL/6 J mice[J].Nutr Metab (Lond),2018,15(1):37.
[81]	STROEVE J H M,BRUFAU G,STELLAARD F,et al.Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice[J].Lab Invest,2010,90(10):1457-1467.
[82]	BALLATORI N,CHRISTIAN W V,WHEELER S G,et al.The heteromeric organic solute transporter,OSTα-OSTβ/SLC51:a transporter for steroid-derived molecules[J].Mol Aspects Med,2013,34(2-3):683-692.
[83]	BALLATORI N,FANG F,CHRISTIAN W V,et al.Ostα-Ostβ is required for bile acid and conjugated steroid disposition in the intestine,kidney,and liver[J].Am J Physiol Gastrointest Liver Physiol,2008,295(1):G179-G186.
[84]	HALPERN M D,HOLUBEC H,SAUNDERS T A,et al.Bile acids induce ileal damage during experimental necrotizing enterocolitis[J].Gastroenterology,2006,130(2):359-372.
[85]	BALLATORI N,CHRISTIAN W V,LEE J Y,et al.OSTα-OSTβ:a major basolateral bile acid and steroid transporter in human intestinal,renal,and biliary epithelia[J].Hepatology,2005,42(6):1270-1279.
[86]	CHRISTIAN W V,LI N,HINKLE P M,et al.β-Subunit of the OSTα-OSTβ organic solute transporter is required not only for heterodimerization and trafficking but also for function[J].J Biol Chem,2012,287(25):21233-21243.
[87]	DAWSON P A,HUBBERT M,HAYWOOD J,et al.The heteromeric organic solute transporter α-β,Ostα-Ostβ,is an ileal basolateral bile acid transporter[J].J Biol Chem,2005,280(8):6960-6968.
[88]	RAO A,HAYWOOD J,CRADDOCK A L,et al.The organic solute transporter α-β,Ostα-Ostβ,is essential for intestinal bile acid transport and homeostasis[J].Proc Natl Acad Sci U S A,2008,105(10):3891-3896.
[89]	SULTAN M,RAO A,ELPELEG O,et al.Organic solute transporter-β(SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis[J].Hepatology,2018,68(2):590-598.
[90]	BOYER J L.OSTα-OSTβ guards the ileal enterocyte from the accumulation of toxic levels of bile acids[J].Cell Mol Gastroenterol Hepatol,2018,5(4):649-650.
[91]	XU S H,SOROKA C J,SUN A Q,et al.A novel Di-Leucine motif at the N-terminus of human organic solute transporter beta is essential for protein association and membrane localization[J].PLoS One,2016,11(6):e0158269.
[92]	WHEELER S G,HAMMOND C L,JORNAYVAZ F R,et al.OSTα-/- mice exhibit altered expression of intestinal lipid absorption genes,resistance to age-related weight gain,and modestly improved insulin sensitivity[J].Am J Physiol Gastrointest Liver Physiol,2014,306(5):G425-G438.
[93]	FERREBEE C B,LI J N,HAYWOOD J,et al.Organic solute transporter α-β protects ileal enterocytes from bile acid-induced injury[J].Cell Mol Gastroenterol Hepatol,2018,5(4):499-522.
[94]	DAWSON P A.Impact of inhibiting ileal apical versus basolateral bile acid transport on cholesterol metabolism and atherosclerosis in mice[J].Dig Dis,2015,33(3):382-387.
[95]	MALINEN M M,ALI I,BEZENÇON J,et al.Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury[J].Am J Physiol Gastrointest Liver Physiol,2018,314(5):G597-G609.
[96]	HAGENBUCH B.Molecular properties of hepatic uptake systems for bile acids and organic anions[J].J Membr Biol,1997,160(1):1-8.
[97]	LEAZER T M,KLAASSEN C D.The presence of xenobiotic transporters in rat placenta[J].Drug Metab Dispos,2003,31(2):153-167.
[98]	ST-PIERRE M V,STALLMACH T,FREIMOSER GRUNDSCHOBER A,et al.Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat[J].Am J Physiol Regul Integr Comp Physiol,2004,287(6):1505-1516.
[99]	FERREBEE C B,LI J N,HAYWOOD J,et al.Organic solute transporter α-β protects Ileal enterocytes from bile acid-induced injury[J].Cell Mol Gastroenterol Hepatol,2018,5(4):499-522.
[100]	BOYER J L.Bile formation and secretion[J].Compr Physiol,2013,3(3):1035-1078.
[101]	KIM J Y,KIM K H,LEE J A,et al.Transporter-mediated bile acid uptake causes Ca2+-dependent cell death in rat pancreatic acinar cells[J].Gastroenterology,2002,122(7):1941-1953.
[102]	NYARKO E,OBIRIKORANG C,OWIREDU W K B A,et al.NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population[J].Virol J,2020,17(1):91.
[103]	KEITEL V,BURDELSKI M,WARSKULAT U,et al.Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis[J].Hepatology,2005,41(5):1160-1172.
[104]	WU M R,HSIAO J K.Apical sodium-dependent bile acid cotransporter,a novel transporter of indocyanine green,and its application in drug screening[J].Int J Mol Sci,2020,21(6):2202.
[105]	HAGENBUCH B,LÜBBERT H,STIEGER B,et al.Expression of the hepatocyte Na+/bile acid cotransporter in Xenopus laevis oocytes[J].J Biol Chem,1990,265(10):5357-5360.
[106]	KOJIMA H,NIES A T,KÖNIG J,et al.Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis[J].J Hepatol,2003,39(5):693-702.
[107]	YAN Y,ALLWEISS L,YANG D L,et al.Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection[J].Emerg Microbes Infect,2019,8(1):879-894.
[108]	ROBIN M J D,APPELMAN M D,VOS H R,et al.Calnexin depletion by endoplasmic reticulum stress during cholestasis inhibits the Na+-taurocholate cotransporting polypeptide[J].Hepatol Commun,2018,2(12):1550-1566.
[109]	OBAIDAT A,ROTH M,HAGENBUCH B.The expression and function of organic anion transporting polypeptides in normal tissues and in cancer[J].Annu Rev Pharmacol Toxicol,2012,52:135-151.
[110]	HAGENBUCH B,MEIER P J.Organic anion transporting polypeptides of the OATP/SLC21 family:phylogenetic classification as OATP/SLCO superfamily,new nomenclature and molecular/functional properties[J].Pflügers Arch,2004,447(5):653-665.
[111]	LI L Q,MEIER P J,BALLATORI N.Oatp2 mediates bidirectional organic solute transport:a role for intracellular glutathione[J].Mol Pharmacol,2000,58(2):335-340.
[112]	APPELMAN M D,ROBIN M J D,VOGELS E W M,et al.The lipid raft component stomatin interacts with the Na+ taurocholate cotransporting polypeptide (NTCP) and modulates bile salt uptake[J].Cells,2020,9(4):986.
[113]	MICHALSKI C,CUI Y H,NIES A T,et al.A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter[J].J Biol Chem,2002,277(45):43058-43063.
[114]	OSWALD M,KULLAK-UBLICK G A,PAUMGARTNER G,et al.Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis[J].Liver,2001,21(4):247-253.
[115]	LI L Q,MEIER P J,BALLATORI N.Oatp2 mediates bidirectional organic solute transport:a role for intracellular glutathione[J].Mol Pharmacol,2000,58(2):335-340.
[116]	GLAVY J S,WU S M,WANG P J,et al.Down-regulation by extracellular ATP of rat hepatocyte organic anion transport is mediated by serine phosphorylation of Oatp1[J].J Biol Chem,2000,275(2):1479-1484.
[117]	JUNG D,HAGENBUCH B,GRESH L,et al.Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1α[J].J Biol Chem,2001,276(40):37206-37214.
[118]	LI T T,AN J X,XU J Y,et al.Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver[J].World J Clin Cases,2019,7(23):3915-3933.
[119]	HALILBASIC E,CLAUDEL T,TRAUNER M.Bile acid transporters and regulatory nuclear receptors in the liver and beyond[J].J Hepatol,2013,58(1):155-168.
[120]	FORMAN B M,GOODE E,CHEN J,et al.Identification of a nuclear receptor that is activated by farnesol metabolites[J].Cell,1995,81(5):687-693.
[121]	MAKISHIMA M,OKAMOTO A Y,REPA J J,et al.Identification of a nuclear receptor for bile acids[J].Science,1999,284(5418):1362-1365.
[122]	ZHANG Y Q,CASTELLANI L W,SINAL C J,et al.Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR[J].Genes Dev,2004,18(2):157-169.
[123]	MAHANTI P,BOSE N,BETHKE A,et al.Comparative metabolomics reveals endogenous ligands of DAF-12,a nuclear hormone receptor,regulating C. elegans development and lifespan[J].Cell Metab,2014,19(1):73-83.
[124]	PENCEK R,MARMON T,ROTH J D,et al.Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers[J].Diabetes Obes Metab,2016,18(9):936-940.
[125]	KEELY S J,WALTERS J R F.The farnesoid X receptor:good for BAD[J].Cell Mol Gastroenterol Hepatol,2016,2(6):725-732.
[126]	SWANN J R,WANT E J,GEIER F M,et al.Systemic gut microbial modulation of bile acid metabolism in host tissue compartments[J].Proc Natl Acad Sci U S A,2011,108(S1):4523-4530.
[127]	HWANG S T,URIZAR N L,MOORE D D,et al.Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor[J].Gastroenterology,2002,122(5):1483-1492.
[128]	KIR S,ZHANG Y,GERARD R D,et al.Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo[J].J Biol Chem,2012,287(49):41334-41341.
[129]	KIM Y C,BYUN S,ZHANG Y,et al.Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2[J].Genome Biol,2015,16(1):268.
[130]	MA Y J,HUANG Y X,YAN L N,et al.Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance[J].Pharm Res,2013,30(5):1447-1457.
[131]	CHAWLA A,REPA J J,EVANS R M,et al.Nuclear receptors and lipid physiology:opening the X-files[J].Science,2001,294(5548):1866-1870.
[132]	SONG X L,KAIMAL R,YAN B F,et al.Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression[J].J Lipid Res,2008,49(5):973-984.
[133]	HONJO Y,SASAKI S,KOBAYASHI Y,et al.1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor[J].J Endocrinol,2006,188(3):635-643.
[134]	GHOSH A,CHEN F,BANERJEE S,et al.c-Fos mediates repression of the apical sodium-dependent bile acid transporter by fibroblast growth factor-19 in mice[J].Am J Physiol Gastrointest Liver Physiol,2014,306(2):G163-G171.
[135]	LEE Y K,SCHMIDT D R,CUMMINS C L,et al.Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis[J].Mol Endocrinol,2008,22(6):1345-1356.
[136]	PAN D H,CHEN F,NEIMARK E,et al.FTF and LRH-1,two related but different transcription factors in human Caco-2 cells:their different roles in the regulation of bile acid transport[J].Biochim Biophys Acta,2005,1732(1-3):31-37.
[137]	NEIMARK E,CHEN F,LI X P,et al.Bile acid-induced negative feedback regulation of the human ileal bile acid transporter[J].Hepatology,2004,40(1):149-156.
[138]	STROEVE J H M,BRUFAU G,STELLAARD F,et al.Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice[J].Lab Invest,2010,90(10):1457-1467.
[139]	ZHANG J H,NOLAN J D,KENNIE S L,et al.Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids[J].Am J Physiol Gastrointest Liver Physiol,2013,304(10):G940-G948.
[140]	ZAGHINI I,LANDRIER J F,GROBER J,et al.Sterol regulatory element-binding protein-1c is responsible for cholesterol regulation of ileal bile acid-binding protein gene in vivo.Possible involvement of liver-X-receptor[J].J Biol Chem,2002,277(2):1324-1331.
[141]	LANDRIER J F,GROBER J,DEMYDCHUK J,et al.FXRE can function as an LXRE in the promoter of human ileal bile acid-binding protein (I-BABP) gene[J].FEBS Lett,2003,553(3):299-303.
[142]	FRANKENBERG T,RAO A,CHEN F,et al.Regulation of the mouse organic solute transporter α-β,OSTα-Ostβ,by bile acids[J].Am J Physiol Gastrointest Liver Physiol,2006,290(5):G912-G922.
[143]	SCHAFFNER C A,MWINYI J,GAI Z B,et al.The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes[J].Liver Int,2015,35(4):1152-1161.
[144]	ZHANG J H,NOLAN J D,KENNIE S L,et al.Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids[J].Am J Physiol Gastrointest Liver Physiol,2013,304(10):G940-G948.
[145]	FRANKENBERG T,RAO A,CHEN F,et al.Regulation of the mouse organic solute transporter α-β,OSTα-Ostβ,by bile acids[J].Am J Physiol Gastrointest Liver Physiol,2006,290(5):G912-G922.
[146]	OKUWAKI M,TAKADA T,IWAYANAGI Y,et al.LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR[J].Pharm Res,2007,24(2):390-398.
[147]	GEIER A,MARTIN I V,DIETRICH C G,et al.Hepatocyte nuclear factor-4α is a central transactivator of the mouse Ntcp gene[J].Am J Physiol Gastrointest Liver Physiol,2008,295(2):G226-G233.
[148]	DIETRICH C G,MARTIN I V,PORN A C,et al.Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4α and PGC1α[J].Am J Physiol Gastrointest Liver Physiol,2007,293(3):G585-G590.
[149]	MEYER ZU SCHWABEDISSEN H E,BÖTTCHER K,CHAUDHRY A,et al.Liver X receptor α and farnesoid X receptor are major transcriptional regulators of OATP1B1[J].Hepatology,2010,52(5):1797-1807.
[150]	ZHANG Y C,RUGGIERO M,HAGENBUCH B.OATP1B3 expression and function is modulated by Coexpression with OCT1,OATP1B1,and NTCP[J].Drug Metab Dispos,2020,48(8):622-630.
[151]	LEE J M,ONG J R,VERGNES L,et al.Diet1,bile acid diarrhea,and FGF15/19:mouse model and human genetic variants[J].J Lipid Res,2018,59(3):429-438.
[152]	QIAN X,YANAGI K,KANE A V,et al.Ridinilazole,a narrow spectrum antibiotic for treatment of Clostridioides difficile infection,enhances preservation of microbiota-dependent bile acids[J].Am J Physiol Gastrointest Liver Physiol,2020,319(2):G227-G237.
[153]	FIORUCCI S,BIAGIOLI M,ZAMPELLA A,et al.Bile acids activated receptors regulate innate immunity[J].Front Immunol,2018,9:1853.
[154]	BROWN J R M,FLEMER B,JOYCE S A,et al.Changes in microbiota composition,bile and fatty acid metabolism,in successful faecal microbiota transplantation for Clostridioides difficile infection[J].BMC Gastroenterol,2018,18(1):131.
[155]	MAHMOUDIANDEHKORDI S,ARNOLD M,NHO K,et al.Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome[J].Alzheimers Dement,2019,15(1):76-92.